Sulfated polymannuroguluronate, a novel anti‐acquired immune deficiency syndrome drug candidate, decreased vulnerability of PC12 cells to human …
Abstract Human immunodeficiency virus (HIV)‐1 infection of the central nervous system
occurs in the vast majority of HIV‐infected patients. HIV‐associated dementia (HAD) …
occurs in the vast majority of HIV‐infected patients. HIV‐associated dementia (HAD) …
Sulfated polymannuroguluronate, a novel anti-acquired immune deficiency syndrome drug candidate, decreased vulnerability of PC12 cells to human …
B Hui, J Li, MY Geng - Journal of neuroscience research, 2008 - pubmed.ncbi.nlm.nih.gov
Human immunodeficiency virus (HIV)-1 infection of the central nervous system occurs in the
vast majority of HIV-infected patients. HIV-associated dementia (HAD) represents the most …
vast majority of HIV-infected patients. HIV-associated dementia (HAD) represents the most …
Sulfated polymannuroguluronate, a novel anti-acquired immune deficiency syndrome drug candidate, decreased vulnerability of PC12 cells to human …
B Hui, J Li, MY Geng - Journal of Neuroscience Research, 2008 - europepmc.org
Human immunodeficiency virus (HIV)-1 infection of the central nervous system occurs in the
vast majority of HIV-infected patients. HIV-associated dementia (HAD) represents the most …
vast majority of HIV-infected patients. HIV-associated dementia (HAD) represents the most …
[PDF][PDF] Bin Hui, Jing Li, and Mei Yu Geng1
Journal of Neuroscience Research, 2008 - academia.edu
Human immunodeficiency virus (HIV)-1 infection of the central nervous system occurs in the
vast majority of HIV-infected patients. HIV-associated dementia (HAD) represents the most …
vast majority of HIV-infected patients. HIV-associated dementia (HAD) represents the most …